CapsoVision (NASDAQ:CV) Posts Quarterly Earnings Results

Posted by Brenda Bartman on Aug 13th, 2026

CapsoVision (NASDAQ:CV – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.15) EPS for the quarter, FiscalAI reports. The company had revenue of $3.64 million for the quarter.

CapsoVision Price Performance

NASDAQ:CV traded down $0.07 during trading hours on Thursday, hitting $6.79. The company had a trading volume of 74,052 shares, compared to its average volume of 258,208. The stock has a 50-day moving average price of $6.80 and a 200 day moving average price of $6.33. The company has a market capitalization of $339.23 million and a PE ratio of -2.90. CapsoVision has a 52 week low of $3.43 and a 52 week high of $15.37.

Insider Buying and Selling

In related news, major shareholder Eliyahou Et Al Harari bought 81,300 shares of the company’s stock in a transaction dated Wednesday, July 8th. The stock was purchased at an average cost of $6.09 per share, with a total value of $495,117.00. Following the transaction, the insider owned 3,282,051 shares in the company, valued at approximately $19,987,690.59. This trade represents a 2.54% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders have acquired 156,218 shares of company stock valued at $1,007,902. 2.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On CapsoVision

Institutional investors have recently bought and sold shares of the stock. Wells Fargo & Company MN grew its holdings in shares of CapsoVision by 66.4% during the 4th quarter. Wells Fargo & Company MN now owns 6,287 shares of the company’s stock worth $67,000 after acquiring an additional 2,508 shares during the period. Deutsche Bank AG purchased a new position in shares of CapsoVision in the 4th quarter valued at approximately $47,000. Virtu Financial LLC bought a new stake in shares of CapsoVision during the fourth quarter valued at approximately $128,000. Millennium Management LLC purchased a new stake in CapsoVision in the fourth quarter worth $163,000. Finally, Bank of America Corp DE grew its stake in CapsoVision by 528.9% in the first quarter. Bank of America Corp DE now owns 22,238 shares of the company’s stock worth $162,000 after purchasing an additional 18,702 shares during the period.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of CapsoVision in a research report on Monday, June 29th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $8.50.

Read Our Latest Analysis on CapsoVision

CapsoVision Company Profile

(Get Free Report)

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.